Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 6Digestive System Neoplasms 4Pancreatic Neoplasms 3Neoplasms, Glandular and Epithelial 3Neoplasms by Site 3Neoplasms 3Digestive System Diseases 3Pancreatic Diseases 2Neoplasms by Histologic Type 2Endocrine Gland Neoplasms 2Carcinoma, Pancreatic Ductal 2Carcinoma, Hepatocellular 2Adenocarcinoma 2Stomach Neoplasms 1Rectal Diseases 1Previously Treated Metastatic Colorectal Cancer 1Pancreatic cancer, adult 1Intestinal Neoplasms 1Intestinal Diseases 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Endocrine System Diseases 1Colonic Diseases 1Carcinoma, Islet Cell 1Advanced Gastrointestinal Cancer 1Adenoma, Islet Cell 1

Interventions

Irinotecan 4Oxaliplatin 3Capecitabine 3Bevacizumab 3Surveys and Questionnaires 2Leucovorin 2Fluorouracil 2Drug Therapy 2Cyclophosphamide 2Colonoscopy 2Cetuximab 2Aspirin 2repotrectinib 1pralsetinib 1pembrolizumab 1napabucasin 1lutetium Lu 177 dotatate 1guadecitabine 1encorafenib 1copper dotatate CU-64 1alectinib 1Ursodeoxycholic Acid 1Pemetrexed 1Oviposition 1Ocoxin 1Lutetium-177 1Lutetium 1Levoleucovorin 1KRN-330 1Folfox protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Intestinal Diseases × napabucasin × Gastrointestinal × Clear all
NCT02753127 2023-11-15

CanStem303C

Sumitomo Pharma America, Inc.

Phase 3 Completed
1,253 enrolled 18 charts
Gastrointestinal

Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Rectal Diseases, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡